News came later, chart already shown sign of bullishness. Bou | Vibhor Varshney

News came later, chart already shown sign of bullishness.

Bought at 1055, now at 1320

Simply 25%


#PharmEasy in talks to buy Thyrocare in deal worth around Rs 7,000 crore.
The deal is likely to announced soon given the IPO timelines of it's parent company API Holdings